API CAS 126784-99-4 Ulipristal Acetate Purity Ulipristal Acetate Powder Raw Materials Ulipristal Acetate

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung Ulipristal Acetate
• Product Name: Ulipristal Acetate
• Name: Ulipristal Acetate Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 126784-99-4
• Mf: C30h37no4
• MW: 475.629
• Boiling Point: 640.1 °c At760mmhg
• Density: 1.19
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

API CAS 126784-99-4 Ulipristal Acetate Purity Ulipristal Acetate Powder Raw Materials Ulipristal Acetate

Product Description

Product Details

Product name	Ulipristal Acetate
Appearance	White powder
CAS NO.	126784-99-4
MF	C30H37NO4
MW	475.629
Boiling point	640.1 °C at760mmHg

Ulipristal acetate (UPA) is a selective progesterone receptor modulator. Attributing to its higher efficacy and a similar rate of side effects compared to levonorgestrel emergency contraception, it is now recommended as first line treatment for emergency contraception. Emergency contraception is defined as the use of drug or device after unprotected or under-protected intercourse to prevent an unwanted pregnancy. Ulipristal acetate can be used up to 5 days (120 h) after unprotected sexual intercourse.
As progesterone promotes the growth of uterine fibroids, the blocking characteristic of ulipristal acetate can thereby be used to reduce the size of uterine fibroids. Ulipristal acetate has also shown efficacy with a significant reduction in uterine bleeding caused by uterine fibroids. The treatment of fibroids by ulipristal acetate should begin in the first week of a menstrual period.

Application&Function

1.Ulipristalacetate is a progesterone agonist/antagonist whose mechanism of action is inhibition or delayed ovulation.

2.Endometrial changes, however, may also is one of the causes of curative effect of acetic acid uri department he belongs to selective progesterone receptor modulators, part of progesterone receptor antagonist and exciting role it and progesterone receptors in the human body to prevent the combination of progesterone and Chemicalbook progesterone receptor acetate uri department his effectiveness depends on the delivery time in the menstrual cycle in the middle of the follicular hyperplasia drug would inhibit ovarian follicles generation and reduce the concentration of estradiol in the periods of peak luteinizing hormone drug can make the follicle delayed crack 5 ~ 9 days
Early luteal administration did not significantly delay endometrial maturation, but reduced endometrial thickness by 0.62.2 mm(mean SD)

Specification